As of 2025-05-22, the EV/EBITDA ratio of Isofol Medical AB (publ) (ISOFOL.ST) is -2.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ISOFOL.ST's latest enterprise value is 97.67 mil SEK. ISOFOL.ST's TTM EBITDA according to its financial statements is -43.70 mil SEK. Dividing these 2 quantities gives us the above ISOFOL.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-05-16 | -3.12 |
| 2025-05-15 | -3.09 |
| 2025-05-14 | -3.05 |
| 2025-05-13 | -2.97 |
| 2025-05-12 | -3.81 |
| 2025-05-09 | -4.67 |
| 2025-05-08 | -4.52 |
| 2025-05-07 | -4.36 |
| 2025-05-06 | -4.52 |
| 2025-05-05 | -4.59 |
| 2025-05-02 | -4.79 |
| 2025-04-30 | -4.64 |
| 2025-04-29 | -4.77 |
| 2025-04-28 | -5.15 |
| 2025-04-25 | -4.82 |
| 2025-04-24 | -4.67 |
| 2025-04-23 | -4.67 |
| 2025-04-22 | -4.23 |
| 2025-04-17 | -4.36 |
| 2025-04-16 | -4.49 |
| 2025-04-15 | -4.41 |
| 2025-04-14 | -4.34 |
| 2025-04-11 | -4.38 |
| 2025-04-10 | -4.34 |
| 2025-04-09 | -4.45 |
| 2025-04-08 | -4.66 |
| 2025-04-07 | -4.64 |
| 2025-04-04 | -5.04 |
| 2025-04-03 | -5.47 |
| 2025-04-02 | -5.09 |
| 2025-04-01 | -4.71 |
| 2025-03-31 | -4.46 |
| 2025-03-28 | -4.93 |
| 2025-03-27 | -5.21 |
| 2025-03-26 | -5.12 |
| 2025-03-25 | -5.43 |
| 2025-03-24 | -5.41 |
| 2025-03-21 | -4.38 |
| 2025-03-20 | -4.08 |
| 2025-03-19 | -3.86 |
| 2025-03-18 | -3.87 |
| 2025-03-17 | -3.80 |
| 2025-03-14 | -3.76 |
| 2025-03-13 | -3.82 |
| 2025-03-12 | -4.08 |
| 2025-03-11 | -3.45 |
| 2025-03-10 | -3.63 |
| 2025-03-07 | -3.73 |
| 2025-03-06 | -3.58 |
| 2025-03-05 | -3.86 |